|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-4-14
|
|
pubmed:abstractText |
Tyrosine kinase mediates cell proliferation and differentiation, and plays important roles in tumorigenesis and development of esophageal carcinoma. STI571 is a tyrosine kinase inhibitor of platelet-derived growth factor receptor beta (PDGFR-beta) which is overexpressed in esophageal carcinoma. This study was to explore the in vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
456-60
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16613680-Antineoplastic Agents,
pubmed-meshheading:16613680-Apoptosis,
pubmed-meshheading:16613680-Cell Line, Tumor,
pubmed-meshheading:16613680-Cell Proliferation,
pubmed-meshheading:16613680-Drug Delivery Systems,
pubmed-meshheading:16613680-Esophageal Neoplasms,
pubmed-meshheading:16613680-Humans,
pubmed-meshheading:16613680-Piperazines,
pubmed-meshheading:16613680-Protein-Tyrosine Kinases,
pubmed-meshheading:16613680-Pyrimidines,
pubmed-meshheading:16613680-Receptor, Platelet-Derived Growth Factor alpha,
pubmed-meshheading:16613680-Receptor, Platelet-Derived Growth Factor beta
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T].
|
|
pubmed:affiliation |
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
